Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) EPS (Weighted Average and Diluted) (2016 - 2026)

Bio-Techne has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.24 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 9.09% year-over-year to $0.24; the TTM value through Dec 2025 reached $0.51, down 49.0%, while the annual FY2025 figure was $0.46, 56.19% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.24 at Bio-Techne, roughly flat from $0.24 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $1.69 in Q3 2021 and troughed at -$2.24 in Q2 2021.
  • A 5-year average of $0.28 and a median of $0.31 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 251.35% in 2021 and later surged 116.96% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.49 in 2021, then tumbled by 36.73% to $0.31 in 2022, then tumbled by 45.16% to $0.17 in 2023, then increased by 29.41% to $0.22 in 2024, then rose by 9.09% to $0.24 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for TECH at $0.24 in Q4 2025, $0.24 in Q3 2025, and -$0.11 in Q2 2025.